Van Hamburg et al. showed that TNF-alpha blockade alone was insufficient to suppress the production of interleukin (IL)-17A and IL-22, which are two key cytokines involved in the pathophysiologic interaction of T helper 17 (Th17) cells and synovial fibroblasts in RA. This evidence concerns the gene IL22 and rheumatoid arthritis.